BRUSSELS: Nyxoah SA (Euronext Brussels/Nasdaq: NYXH), a medical technology company, announced Tuesday a combined financing package of up to approximately €67 million (U.S. $77.6 million) to support the commercialization and development of its Genio system for treating Obstructive Sleep Apnea (OSA). The financing consists of three components: a €17 million private placement in Europe, a…
STOCKHOLM: Swedish medical technology and life sciences investor MedCap AB on Friday reported a 32% rise in its third-quarter adjusted core earnings, driven by robust organic growth and contributions from recent acquisitions. The company, which buys and develops small- and medium-sized life science companies, said adjusted earnings before interest, taxes and amortisation (EBITA) rose to…
CAMBRIDGE: EDX Medical Group plc has secured up to £4 million in funding to advance its portfolio of digital diagnostic products and services, the company announced Monday. The financing includes £2 million raised through the issue of 14,285,713 new ordinary shares at 14p per share, and a further £2 million via a convertible loan note…
SYDNEY: Next Science Limited (ASX:NXS), an Australian medical technology company, announced Tuesday it has entered into a binding agreement to sell the majority of its assets to Italy-based Demetra Holdings S.p.A. for $50 million. The deal includes the sale of regulatory approvals, intellectual property, inventory, and other assets but excludes Next Science’s diabetic foot infection…
WARSAW: Zimmer Biomet Holdings Inc. (NYSE: ZBH), a global medical technology leader, signed a definitive agreement to acquire OrthoGrid Systems Inc., a privately-held medical technology company focused on artificial intelligence (AI)-driven surgical guidance systems for total hip replacement. The acquisition includes OrthoGrid’s AI-powered, fluoroscopy-based surgical assistance platform Hip AI, as well as two additional FDA-cleared…
Kelyniam Global (OTC:KLYG), a renowned custom cranial implant manufacturer, has released its financial results for the year ending December 31, 2023. CEO Ross Bjella announced a record-setting fourth quarter in unit sales, contributing to a modest increase in unit volume over the previous year. Despite this, the company experienced a 12% decline in total revenue,…
MELBOURNE, AUSTRALIA: Respiratory imaging technology company 4DMedical Limited has signed a binding agreement for the acquisition of Imbio, a U.S.-based medical technology company that uses artificial intelligence (AI) to turn standard-of-care CT scans into personalised medicine for transforming the way patients are diagnosed, treated, and managed. Imbio will be acquired for an upfront purchase price…